ES512969A0 - "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina". - Google Patents

"un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".

Info

Publication number
ES512969A0
ES512969A0 ES512969A ES512969A ES512969A0 ES 512969 A0 ES512969 A0 ES 512969A0 ES 512969 A ES512969 A ES 512969A ES 512969 A ES512969 A ES 512969A ES 512969 A0 ES512969 A0 ES 512969A0
Authority
ES
Spain
Prior art keywords
chinolein
naftiridine
compounds
procedure
preparing salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES512969A
Other languages
English (en)
Other versions
ES8304117A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES8304117A1 publication Critical patent/ES8304117A1/es
Publication of ES512969A0 publication Critical patent/ES512969A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
ES512969A 1981-06-11 1982-06-09 "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina". Granted ES512969A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27260181A 1981-06-11 1981-06-11
US33418281A 1981-12-24 1981-12-24

Publications (2)

Publication Number Publication Date
ES8304117A1 ES8304117A1 (es) 1983-02-16
ES512969A0 true ES512969A0 (es) 1983-02-16

Family

ID=26955624

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512969A Granted ES512969A0 (es) 1981-06-11 1982-06-09 "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".

Country Status (17)

Country Link
EP (1) EP0067666B1 (es)
KR (1) KR880002087B1 (es)
AU (1) AU551596B2 (es)
CA (1) CA1191842A (es)
DD (1) DD202561A5 (es)
DE (1) DE3267135D1 (es)
DK (1) DK155998C (es)
ES (1) ES512969A0 (es)
FI (1) FI78292C (es)
GR (1) GR77194B (es)
HU (1) HU188181B (es)
IE (1) IE53259B1 (es)
IL (1) IL66027A (es)
NO (1) NO157739C (es)
NZ (1) NZ200908A (es)
PH (1) PH19091A (es)
SU (1) SU1192624A3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
IT1196051B (it) * 1984-03-16 1988-11-10 Schiena Ricerche Composti ad attivita' antibatterica
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
HUT40429A (en) * 1985-04-29 1986-12-28 Chinoin Gyogyszer Es Vegyeszet Process for production of salts of derivatives of kynolin carbonic acid
DE3525335A1 (de) * 1985-07-16 1987-01-22 Bayer Ag Embonate von chinoloncarbonsaeuren und ihren derivaten
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
IL80459A (en) * 1986-10-30 1991-04-15 Abic Ltd Water-soluble adduct of norfloxacin and nicotinic acid
US5188833A (en) * 1987-12-28 1993-02-23 Kyorin Seiyaku Kabushiki Kaisha Freeze-dried pharmaceutical preparations for parenteral use
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤
US4948894A (en) * 1989-02-21 1990-08-14 American Cyanamid Company 8-fluoro and 7, 8, 10-trifluoro-9-(substituted)-6-oxo-6H-benzo-(C)quinolizine-5-carboxylic acids
KR0159540B1 (ko) * 1992-01-21 1998-12-01 김정순 퀴놀론-카복실산의 염 및 그 함유조성물
ES2127036B1 (es) * 1994-03-21 1999-11-16 Ind Quimica Agropecuaria S A Aducto de norfloxacina soluble en agua.
ES2088742B1 (es) * 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US8324238B2 (en) 2007-04-13 2012-12-04 Dong Wha Pharmaceutical Co. Ltd. Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
ZA811304B (en) * 1980-03-11 1982-06-30 Warner Lambert Co Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide

Also Published As

Publication number Publication date
HU188181B (en) 1986-03-28
ES8304117A1 (es) 1983-02-16
GR77194B (es) 1984-09-11
AU8475782A (en) 1982-12-16
DD202561A5 (de) 1983-09-21
EP0067666A1 (en) 1982-12-22
EP0067666B1 (en) 1985-10-30
AU551596B2 (en) 1986-05-08
DK155998C (da) 1989-11-06
FI78292B (fi) 1989-03-31
DE3267135D1 (en) 1985-12-05
IL66027A (en) 1986-02-28
NZ200908A (en) 1984-09-28
DK261582A (da) 1982-12-12
NO157739B (no) 1988-02-01
IE53259B1 (en) 1988-09-28
PH19091A (en) 1985-12-19
KR880002087B1 (ko) 1988-10-15
NO157739C (no) 1988-05-11
CA1191842A (en) 1985-08-13
FI78292C (fi) 1989-07-10
KR840000544A (ko) 1984-02-25
DK155998B (da) 1989-06-12
IE821390L (en) 1982-12-11
SU1192624A3 (ru) 1985-11-15
IL66027A0 (en) 1982-09-30
NO821931L (no) 1982-12-13
FI822066A0 (fi) 1982-06-10

Similar Documents

Publication Publication Date Title
ES511152A0 (es) "un procedimiento para prepara derivados de fenilciclobutano".
ES533821A0 (es) Procedimiento para preparar n2-acil-9-(1, 3-dihidroxi-2-propoximetil)-guaninas y sus sales farmaceuticamente aceptables
ES512969A0 (es) "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
ES551538A0 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidro-4-oxonaftiridina y sus sales
ES515191A0 (es) "un procedimiento para la preparacion de sales de s-adenosilmetionina".
AR241158A1 (es) Un procedimiento para la preparacion de compuestos de beta-lactamas y sus sales
ES512852A0 (es) "un procedimiento para preparar nuevos derivados de la n-dihidrotiazolil-3-quinolein-carboxamida".
ES515295A0 (es) "un procedimiento para la preparacion de imidazoquinazolinas".
ES510996A0 (es) "un procedimiento para preparar compuestos de cefem".
ES514652A0 (es) "un procedimiento para preparar compuestos de cefem".
ES510624A0 (es) "un procedimiento para preparar una laca de nitrocelulosa".
ES510036A0 (es) "un procedimiento para la preparacion de derivados de tiazolidina".
ES510908A0 (es) "un procedimiento para la preparacion de derivados de piridinona".
ES516184A0 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
ES510913A0 (es) "un procedimiento para la preparacion de derivados de piridina".
ES511329A0 (es) "procedimiento de preparacion de nuevos derivados imidazotiazoles y de sus sales".
ES510286A0 (es) "un procedimiento para la preparacion de nuevas fluoro-prostaciclinas".
ES514572A0 (es) "un procedimiento para la preparacion de glutation".
ES519853A0 (es) Un procedimiento para la preparacion de derivados de anilinay sus sales.
ES512520A0 (es) "un procedimiento para preparar derivados heterociclicos de amidoximas".
ES508152A0 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
ES513398A0 (es) "un procedimiento para preparar derivados de dialcohilpirazol".
ES514571A0 (es) "un procedimiento para la preparacion de glutation".
ES510928A0 (es) "un procedimiento para la preparacion de mercapto-acil-carnitinas".
ES514464A0 (es) "un procedimiento de preparacion de amino-4-butiramida y sus sales".

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401